Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Caparello

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Clinical Lung Cancer|September 15, 2010
Second-line treatment for non-small-cell lung cancer: one size does not fit allSara Caponi, Enrico Vasile, Laura Ginocchi, et al.
Future Oncology (London, England)|February 18, 2016
Second-line therapy for advanced pancreatic cancer: evaluation of prognostic factors and review of current literatureChiara Caparello, Caterina Vivaldi, Lorenzo Fornaro, et al.
The International Journal of Biological Markers|December 3, 2014
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA databaseRodolfo Sacco, Valeria Mismas, Alessandro Granito, et al.
Future Oncology (London, England)|February 5, 2014
Dissecting signaling pathways in hepatocellular carcinoma: new perspectives in medical therapyLorenzo Fornaro, Caterina Vivaldi, Chiara Caparello, et al.
European Journal of Gastroenterology & Hepatology|August 15, 2009
Computer simulator among experts involved in screening colonoscopyPaolo Cantù, Ausilia Grigolon, Chiara Caparello, et al.
Scientific Reports|August 13, 2017
Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancerMarzia Del Re, Caterina Vivaldi, Eleonora Rofi, et al.
Annals of Surgery|November 6, 2018
Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal AdenocarcinomaLaura L Meijer, Ingrid Garajová, Chiara Caparello, et al.
World Journal of Gastroenterology|September 10, 2016
FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancerChiara Caparello, Laura L Meijer, Ingrid Garajova, et al.
Cancers|February 13, 2026
Current Landscape and Evolving Role of Targeted Agents in Urothelial CarcinomaEnrico Sammarco, Antonio Pellino, Eleonora Bona, et al.
British Journal of Cancer|March 7, 2018
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLCMarzia Del Re, Riccardo Marconcini, Giulia Pasquini, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical Lung Cancer|September 15, 2010
Second-line treatment for non-small-cell lung cancer: one size does not fit allSara Caponi, Enrico Vasile, Laura Ginocchi, et al.
Future Oncology (London, England)|February 18, 2016
Second-line therapy for advanced pancreatic cancer: evaluation of prognostic factors and review of current literatureChiara Caparello, Caterina Vivaldi, Lorenzo Fornaro, et al.
The International Journal of Biological Markers|December 3, 2014
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA databaseRodolfo Sacco, Valeria Mismas, Alessandro Granito, et al.
Future Oncology (London, England)|February 5, 2014
Dissecting signaling pathways in hepatocellular carcinoma: new perspectives in medical therapyLorenzo Fornaro, Caterina Vivaldi, Chiara Caparello, et al.
European Journal of Gastroenterology & Hepatology|August 15, 2009
Computer simulator among experts involved in screening colonoscopyPaolo Cantù, Ausilia Grigolon, Chiara Caparello, et al.
Scientific Reports|August 13, 2017
Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancerMarzia Del Re, Caterina Vivaldi, Eleonora Rofi, et al.
Annals of Surgery|November 6, 2018
Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal AdenocarcinomaLaura L Meijer, Ingrid Garajová, Chiara Caparello, et al.
World Journal of Gastroenterology|September 10, 2016
FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancerChiara Caparello, Laura L Meijer, Ingrid Garajova, et al.
Cancers|February 13, 2026
Current Landscape and Evolving Role of Targeted Agents in Urothelial CarcinomaEnrico Sammarco, Antonio Pellino, Eleonora Bona, et al.
British Journal of Cancer|March 7, 2018
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLCMarzia Del Re, Riccardo Marconcini, Giulia Pasquini, et al.
Pageof 3